Last reviewed · How we verify
NCT06379178
Effect of Oral Colostrum Applications Every 2 Hours and 4 Hours In Order to Achieve Trophic Feeding in Preterm Infants
NA trial testing Oral colostrum application 2 hours in Trophic Feeding in 47 participants. Completed in 31 August 2023.
15 August 2023
Quick facts
| Lead sponsor | Gadjah Mada University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 47 |
| Start date | 19 February 2023 |
| Primary completion | 15 August 2023 |
| Estimated completion | 31 August 2023 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- Oral colostrum application 2 hours
- Oral colostrum application 4 hours
Conditions studied
- Trophic Feeding — all drugs for Trophic Feeding →
- Very Low Birth Weight Baby — all drugs for Very Low Birth Weight Baby →
- Preterm — all drugs for Preterm →
Sponsor
Gadjah Mada University
Who can join
Under 2 Days, any sex, with Trophic Feeding or Very Low Birth Weight Baby. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is aims to evaluate the effects of applying colostrum orally every 4 and 2 hours in order to achieve trophic feeding in preterm infants. The main question it aims to answer is the optimal frequency of colostrum application that can be applied Participants will be divided by randomization using permutation blocks after meeting the inclusion and exclusion criteria and deemed eligible. These blocks were then randomized using computer software such as Microsoft Excel, determining the sequence for allocation to the control and intervention groups based on the randomization order from the permutation code, every 2 hours and every 4 hours. Researchers will investigate the effects of oropharyngeal colostrum application frequency, every 4 hours and every 2 hours, in order to achieve trophic feeding in preterm infants \<34 weeks gestational age.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06379178
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Gadjah Mada University trials
Trials by the same sponsor.
- NCT07476573 — Clinical Trial of Lactiplantibacillus Plantarum Dad-13 on Gut Microbiota Profile and Performance in Adolescent Athletes · NA · not yet recruiting
- NCT07198828 — Mobile Health (mHealth) Application for Smoking Cessation Among Adolescents in Indonesia · NA · not yet recruiting
- NCT07373080 — Brief Culturally Adapted Behavioral Activation Therapy for Adults With Depression in Rural Indonesian Primary Care: A Ty · NA · not yet recruiting
- NCT07349082 — Sensory Block Onset: Epidural vs Dural Puncture Epidural in Cesarean Section · NA · not yet recruiting
- NCT07320534 — Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06379178 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gadjah Mada University
- Last refreshed: 23 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06379178.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing